Chronic Lymphocytic Leukemia

>

Latest News

Oncologists Discuss a Second-Generation BTK for Relapsed/Refractory CLL
Oncologists Discuss a Second-Generation BTK for Relapsed/Refractory CLL

December 18th 2024

During a Case-Based Roundtable® event, Daniel A. Ermann, MD, discussed evaluation and treatment for a patient with relapsed chronic lymphocytic leukemia after receiving venetoclax and obinutuzumab.

BCL2 and cBTK Inhibitors Show Superior Outcomes in CLL/SLL
BCL2 and cBTK Inhibitors Show Superior Outcomes in CLL/SLL

December 12th 2024

Pirtobrutinib Combination Shows High uMRD Rate in CLL
Pirtobrutinib Combination Shows High uMRD Rate in CLL

December 12th 2024

Novel BTK Degrader BGB-16673 Shows Activity in WM and CLL/SLL
Novel BTK Degrader BGB-16673 Shows Activity in WM and CLL/SLL

December 10th 2024

Pirtobrutinib Boosts PFS and Sustains BTK Inhibition in Patients With CLL/SLL
Pirtobrutinib Boosts PFS and Sustains BTK Inhibition in Patients With CLL/SLL

December 10th 2024

Video Series
Video Interviews
Podcasts

More News